Join
Live feed
·
PRReleasevia Quantisnow
Arcellx Inc. logo
Gilead Sciences Inc. logo

Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma

ByQuantisnow·Wall Street's wire, on your screen.
ACLX· Arcellx Inc.GILD· Gilead Sciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACLX (Arcellx Inc.), GILD (Gilead Sciences Inc.) and more on Quantisnow.